Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack-Reference-Cited by-同舟云学术

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack

Published:2017-08 Issue:8 Volume:48 Page:2142-2149
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Coleman Craig I.¹,Peacock W. Frank¹,Bunz Thomas J.¹,Alberts Mark J.¹

Affiliation:

1. From the University of Connecticut School of Pharmacy, Storrs (C.I.C.); Department of Emergency Medicine, Baylor College of Medicine, Houston, TX (W.F.P.); Crystal Run Healthcare, Middletown, NY (T.J.B.); Ayer Neuroscience Institute, Hartford HealthCare, CT (M.J.A.); and Department of Neurology, Hartford Hospital, CT (M.J.A.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference21 articles.

1. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

3. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

4. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

5. Truven Health Analytics. MarketScan Research Databases. http://truvenhealth.com/Portals/0/assets/ACRS_11223_0912_MarketScanResearch_SS_Web.pdf. Accessed December 15 2016.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of haemoglobin A1c variability with adverse outcomes in patients with atrial fibrillation prescribed anticoagulants;European Journal of Preventive Cardiology;2024-08-14

2. To treat or not to treat: a comparative effectiveness analysis of oral anticoagulant outcomes among U.S. nursing home residents with atrial fibrillation;BMC Geriatrics;2024-07-19

3. Is It Time to Expand the Indication of DOAC to Patients With Cardiac Amyloidosis and Atrial Fibrillation?;International Journal of Heart Failure;2024

4. Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults;Journal of the American Geriatrics Society;2023-12-23

5. Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 1;European Cardiology Review;2023-12-15